June 2020 Vol 6 No 3

Tabrecta Approved for NSCLC with MET Biomarker
BiomarkersFDA Approvals, News & Updates
In May 2020, the FDA approved Tabrecta, a new targeted therapy for the treatment of patients with metastatic non–small-cell lung cancer that is associated with the MET biomarker.
Biomarker Testing in Non–Small-Cell Lung Cancer: A Guide for Patients
BiomarkersLung Cancer

Non–small-cell lung cancer, or NSCLC, is the most common form of lung cancer, accounting for about 80% to 85% of all lung cancer cases in the United States.

Proton Therapy Improves Outcomes, Reduces Radiation Side Effects in Patients with Cancer
Proton TherapyRadiation Therapy
Proton therapy has advantages over traditional radiation in reducing radiation side effects and improving patient outcomes. However, many patients and their oncologists are not familiar with this newer form of radiation therapy.
Navigating Through Cancer: Julie Behan, a Compassionate Patient Navigator
From Your Navigator
Julie Behan has been a patient navigator at the American Cancer Society for 24 years. Her story reveals unusual dedication and determination in helping patients with cancer get the care and support they need.
Zejula Now Approved as First-Line Maintenance Therapy in All Patients with Ovarian Cancer
FDA Approvals, News & UpdatesOvarian Cancer
In April 2020, the FDA approved Zejula for long-term maintenance therapy for all patients with advanced ovarian cancer, regardless of any gene mutations.
The 6 Elements I Attribute to My Survival
Brandi Benson took a radical approach when she was diagnosed with Ewing sarcoma. Focusing on making positive and holistic changes gave her the emotional and physical strength to battle her cancer.
Sex During a Cancer Diagnosis and Treatment: What You Need to Know: Interview with Daniel Vorobiof, MD
Sexuality & Cancer
Dr. Daniel Vorobiof, an oncologist and an expert on sexuality, addresses some of the common misconceptions about sexuality during cancer treatment and offers strategies for dealing with the changes that couples may experience.
Making Modifications to Keep a Loved One at Home
CaregiversFamily Members
When his 91-year-old mother-in-law needed full-time care after her colon cancer diagnosis, Mark Ryan made some adjustments in the family home to ensure her comfort and well-being.
Treatment of CLL Should Be Determined by the Patient’s Risk Level
A new long-term study suggests that the choice of treatment for patients with chronic lymphocytic leukemia should be based on the risk level of their disease. Patients at high risk should consider joining a clinical trial with novel agents.
Page 1 of 2
Results 1 - 10 of 19

Subscribe to CONQUER: the patient voice

Receive timely cancer news & updates, patient stories, and more.

Race or Ethnicity
Profession or Role
Primary Interest
Other Interests